skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Recombinant Human Papillomavirus Bivalent Vaccine (Code C48395)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Human Papillomavirus Bivalent Vaccine

Definition: A recombinant, bivalent, human papillomavirus (HPV) vaccine, containing virus-like particles for HPV types 16 and 18 linked to the adjuvant ASO4, with potential immunoprotective and antineoplastic properties. Upon administration, HPV 16/18 L1 virus-like particle/ASO4 vaccine may generate humoral and cellular immunity against HPV types-16 and -18 antigens, thereby preventing cervical infection upon exposure to HPV types 16 and 18. In addition, this agent may stimulate an antitumoral cellular immune response against cervical cancer associated with HPV infection.

NCI-GLOSS Definition: A vaccine used to prevent cervical cancer caused by human papillomaviruses (HPV) types 16 and 18. It is also used to prevent lesions that are caused by these viruses and that can lead to cervical, vulvar, or vaginal cancer. Cervarix is used in females aged 10-25 years. It is also being studied in the treatment of other medical conditions. It is a type of bivalent vaccine.

Display Name: Recombinant Human Papillomavirus Bivalent Vaccine

Label: Recombinant Human Papillomavirus Bivalent Vaccine

NCI Thesaurus Code: C48395 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1721789  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
HPV 16/18 L1 VLP/AS04 VAC
HPV-16/18 VLP/AS04 Vaccine
human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
Human Papillomavirus Bivalent Types 16 and 18 Vaccine, Recombinant
Human Papillomavirus Vaccine L1 16,18
Human Papillomavirus Vaccine, L1 Type 16, 18
Recombinant HPV Bivalent Vaccine
Recombinant Human Papillomavirus Bivalent Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 442270
PDQ Open Trial Search ID 442270 (check for NCI PDQ open clinical trial info)
UMLS CUI C1721789

Other Properties:
     Name Value (qualifiers indented underneath)
code C48395
Contributing_Source CTRP
Legacy_Concept_Name Human_Papillomavirus_16_18_L1_Virus-Like_Particle_AS04_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom